Stay updated on Cabozantinib-Pemetrexed in Lung, Urothelial, Mesothelioma Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib-Pemetrexed in Lung, Urothelial, Mesothelioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib-Pemetrexed in Lung, Urothelial, Mesothelioma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Access to the NCT04173338 study record is replaced by a 403 Forbidden error, removing the study details and related content from the page. This change alters how users view the trial information by displaying an access-denied page instead of the study record.
    Difference
    17%
    Check dated 2026-09-20T20:09:52.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Revision updated from v3.6.5 to v3.6.6, indicating a site version update. The visible study information remains the same, with no changes to the study details on the page.
    Difference
    0.1%
    Check dated 2026-08-30T17:01:36.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    FDA-regulated drug and device indicators were added to the study record, along with an expanded set of MeSH terms and updated metadata such as study dates and enrollment. The previous error-page content was removed, and the page now displays the standard ClinicalTrials.gov study details for this trial.
    Difference
    43%
    Check dated 2026-08-16T14:33:04.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.4 to v3.6.5, indicating a backend or formatting update to the ClinicalTrials.gov page rather than a substantive change to the study content.
    Difference
    16%
    Check dated 2026-08-09T08:57:51.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.3 to v3.6.4, indicating a software update. No study details or content appear to be affected.
    Difference
    0.1%
    Check dated 2026-07-25T18:12:40.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Page revision tag updated from v3.6.2 to v3.6.3, signaling a new build of the ClinicalTrials.gov page. This update does not appear to alter the study details or user-facing content.
    Difference
    0.1%
    Check dated 2026-07-04T13:30:02.000Z thumbnail image

Stay in the know with updates to Cabozantinib-Pemetrexed in Lung, Urothelial, Mesothelioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib-Pemetrexed in Lung, Urothelial, Mesothelioma Clinical Trial page.